Get started
Author

Mitchell Sabloff

Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
2016 · Harold L Atkins, Marjorie Bowman, et al. · The Lancet · 325
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
2017 · Lori Muffly, Marcelo C. Pasquini, et al. · Blood · 297
PDF
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche
2017 · Allison L. Boyd, Jennifer C. Reid, et al. · Nature Cell Biology · 206
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome–negative acute lymphoblastic leukemia in first and second complete remission
2010 · David I. Marks, Tao Wang, et al. · Blood · 203
PDF
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
2010 · Vikas Gupta, Martin S. Tallman, et al. · Blood · 186
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI
2013 · Edward A. Copelan, Betty K. Hamilton, et al. · Blood · 184
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors
2010 · V. Gupta, M. Eapen, et al. · Haematologica · 165
PDF
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
2013 · Amin M. Alousi, Jennifer Le-Rademacher, et al. · Blood · 134
HLA-matched sibling bone marrow transplantation for β-thalassemia major
2010 · Mitchell Sabloff, Mammen Chandy, et al. · Blood · 133
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation
2016 · Adam Bryant, Harold Atkins, et al. · JAMA Neurology · 104
PDF
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group
2013 · Diego Villa, Michael Crump, et al. · Journal of Clinical Oncology · 100
Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS ‐ CAN prospective study
2016 · Rena Buckstein, Richard A. Wells, et al. · British Journal of Haematology · 97
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
2017 · Partow Kebriaei, Claudio Anasetti, et al. · Transplantation and Cellular Therapy · 96
PDF
Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
2023 · Guillermo Garcia-Manero, James McCloskey, et al. · The Lancet Haematology · 93
Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis
2017 · Juliana Barrera-Ramirez, Jessie R. Lavoie, et al. · Stem Cell Reviews and Reports · 90
PDF
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission
2008 · David I. Marks, Waleska S. Pérez, et al. · Blood · 84
PDF
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
2016 · Brian C. Shaffer, Kwang Woo Ahn, et al. · Journal of Clinical Oncology · 75
Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study
2014 · Kristjan Paulson, Anna Serebrin, et al. · British Journal of Haematology · 75
Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors
2015 · Priya Chandran, Yevgeniya Le, et al. · Leukemia Research · 72
Comparison of Outcomes after Transplantation of G-CSF–Stimulated Bone Marrow Grafts versus Bone Marrow or Peripheral Blood Grafts from HLA-Matched Sibling Donors for Patients with Severe Aplastic Anemia
2010 · Roland Chu, Ruta Brazauskas, et al. · Transplantation and Cellular Therapy · 70
PDF
Total Body Irradiation for Hematopoietic Stem Cell Transplantation: What Can We Agree on?
2021 · Mitchell Sabloff, Steven Tisseverasinghe, et al. · Current Oncology · 67
PDF
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an MDS ‐ CAN analysis
2017 · Heather A. Leitch, Ambica Parmar, et al. · British Journal of Haematology · 64
PDF
Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ASTX727 (cedazuridine/decitabine) Compared to IV Decitabine
2019 · Guillermo Garcia-Manero, James McCloskey, et al. · Blood · 61
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia
2017 · Hien Duong Liu, Kwang Woo Ahn, et al. · Transplantation and Cellular Therapy · 61
PDF
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis
2016 · Abhinav Deol, Salyka Sengsayadeth, et al. · Cancer · 59
Works count: 205
Citation count: 4,399
H-index: 34
I10-index: 66
Year
Topic
Type